FoRx Therapeutics discloses its Board with Dr Colin Goddard as Executive Chairman and announces €10m seed financing led by M Ventures, Novartis Venture Fund and Omega Funds

– SWITZERLAND, Basel –  FoRx Therapeutics AG, the biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways, today announced the closing of a EUR 10 million seed financing led by M Ventures, Novartis Venture Fund and Omega Funds.

Scipio bioscience announces €6m Series A funding led by M Ventures

– FRANCE, Paris –  Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6M Series A financing from an international syndicate led by M Ventures, the corporate venture capital arm of Merck.…

Ribometrix announces Hakan Goker to its Board along with raising $30m Series A financing led by M Ventures

– USA, NC – Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced today that it has completed a $30 million Series A financing to advance its discovery platform and internal pipeline of novel small molecule drugs that directly modulate RNA activity, as well as expand its team and business development activity.…